| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/03/2009 | US7485669 Blockade of sodium channels by phenol derivatives |
| 02/03/2009 | US7485663 dissolving in a solvent, precipitating crystal form by cooling the solution to about -20C |
| 02/03/2009 | US7485655 2-Aminothiazole allosteric enhancers of A1 adenosine receptors |
| 02/03/2009 | US7485654 Corneal perception recovery drug containing amide compound |
| 02/03/2009 | US7485647 2-aminoquinoline derivatives |
| 02/03/2009 | US7485642 Administering levosimendan or a salt thereof |
| 02/03/2009 | US7485639 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
| 02/03/2009 | US7485628 Inhibition of STAT-1 |
| 02/03/2009 | US7485626 Biosynthesis of Dna ; cell proliferation; overlapping enzyme activation ; mixture of proteolytic enzyme and dipeptidyl peptidase inhibitors; autoimmune disease; antiinflammatory agents graft versus host diease |
| 02/03/2009 | US7485456 Drug screening for a molecule capable of binding to NIK (nuclear factor kappa B inducing kinase); DNA sequence encoding a protein capable of binding to a tumor necrosis factor receptor-associated factor (TRAF) molecule, TRAF-binding proteins, isoforms, analogs, fragments and derivatives; gene expression |
| 02/03/2009 | US7485449 Nucleic acids encoding sodium channel scn3a alpha subunits |
| 02/03/2009 | US7485429 Genetically engineered polypeptide comprising extracellular domain of integrin subunit alpha 11; marker or target of all types of cells; drugs, vaccines |
| 02/03/2009 | US7485327 For use in pharmaceuticals, dietetics and/or cosmetics; anticancer agents; for treatment of vision defects and periodontal disease |
| 02/03/2009 | US7485314 Induction of antigen specific immunologic tolerance |
| 02/03/2009 | US7485285 Delivery of antidepressants through an inhalation route |
| 02/03/2009 | CA2425164C (4-acylaminopiperidin-1-yl)acetamides as neurokinin antagonists |
| 02/03/2009 | CA2420040C New phenylalanine derivatives |
| 02/03/2009 | CA2392804C Combined agents for treatment of glaucoma |
| 02/03/2009 | CA2388244C Agents for promoting fattening of animals and method of promoting fattening |
| 02/03/2009 | CA2354042C Bioflavonoids, anthocyanins and phenolic compounds from cherries for inhibiting inflammation |
| 02/03/2009 | CA2341397C Immediate release tablet |
| 02/03/2009 | CA2323150C New porphyrins and their use |
| 02/03/2009 | CA2315050C Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof |
| 02/03/2009 | CA2314607C Use of ppar-.gamma. activators in dermatology |
| 02/03/2009 | CA1341590C Human immune interferon |
| 01/29/2009 | WO2009014605A2 Methods and systems relating to mitochondrial dna phenotypes |
| 01/29/2009 | WO2009014217A1 Bicyclic pyrrole derivative |
| 01/29/2009 | WO2009014150A1 Benzimidazole derivative |
| 01/29/2009 | WO2009014100A1 p27 PROTEIN INDUCER |
| 01/29/2009 | WO2009013915A1 Inhibitor of plasminogen activator inhibitor-1 |
| 01/29/2009 | WO2009013885A1 Inhibitor of the differentiation of t cells into th1 cells |
| 01/29/2009 | WO2009013723A2 Ethyl pyruvate alone or in combination with mi cro- clustered water and use of the same |
| 01/29/2009 | WO2009012901A2 Material compositions which comprise adult stem cells obtained from exocrine glandular tissue, in particular for use in regenerative medicine, e.g. for restoring injured or damaged myocardial tissue |
| 01/29/2009 | WO2008082839A3 Pim kinase inhibitors as cancer chemotherapeutics |
| 01/29/2009 | US20090030089 Silicon Substituted Oxyapatite |
| 01/29/2009 | US20090030056 Novel sodium channel blockers |
| 01/29/2009 | US20090030051 Inhibitors of IMPDH enzyme |
| 01/29/2009 | US20090030032 Bicyclic Compound, Production and Use Thereof |
| 01/29/2009 | US20090030029 Novel benzonaphthyridines |
| 01/29/2009 | US20090030023 Pyrimidine compounds and medicinal composition thereof |
| 01/29/2009 | US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/29/2009 | US20090029986 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
| 01/29/2009 | US20090029978 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 01/29/2009 | US20090029973 growth factor receptor tyrosine kinase inhibitor; anticarcinogenic agents; N-{2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-3-hydroxy-3-methylbutanamide |
| 01/29/2009 | US20090029942 Administration of copper to an animal |
| 01/29/2009 | US20090029935 Centrosomal proteins and secretion |
| 01/29/2009 | US20090029922 Use of S1P receptor agonists in heart diseases |
| 01/29/2009 | US20090029914 Albumin Fusion Proteins |
| 01/29/2009 | US20090029444 Novel recombinant anticoagulant proteins |
| 01/29/2009 | US20090029415 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 01/29/2009 | US20090028956 Polypeptide microparticles |
| 01/29/2009 | US20090028887 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/29/2009 | US20090028867 Antagonists Specific For Denatured Collagen And Methods Of Using Same |
| 01/29/2009 | US20090028848 Sequence based engineering and optimization of single chain antibodies |
| 01/29/2009 | US20090028838 Hematopoietic cell culture nutrient supplement |
| 01/29/2009 | US20090028837 Methods for Altering the Reactivity of Plant Cell Walls |
| 01/29/2009 | US20090028836 Stem and progenitor cell expansion by evi, evi-like genes and setbp1 |
| 01/29/2009 | US20090028831 Stem cell regulator, compositions and methods of use |
| 01/29/2009 | US20090028830 Preparation of multipotent stem cells and the use thereof |
| 01/29/2009 | US20090028824 Systems and methods for delivering drugs |
| 01/29/2009 | US20090028819 comprising granulocyte colony stimulating factor peripheral blood stem cells (CD 34) for prevention of spontaneous abortion, preeclampsia, preterm labor or implantation failure during assisted reproduction |
| 01/29/2009 | US20090028814 High molecular weight medicine-containing preparation in powder form for administration through mucosa |
| 01/29/2009 | US20090028804 AhR mediators |
| 01/29/2009 | US20090028800 Method of Treating Postpartum Depression and Aggression |
| 01/29/2009 | CA2694216A1 Benzimidazole derivative |
| 01/29/2009 | CA2693967A1 Heterocyclic amide compounds as protein kinase inhibitors |
| 01/28/2009 | EP2019098A1 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor |
| 01/28/2009 | EP2019094A1 Heterocyclic type cinnamide derivative |
| 01/28/2009 | EP2018873A1 Prophylactic/therapeutic agent for cancer |
| 01/28/2009 | EP2018872A1 Pharmaceutical product |
| 01/28/2009 | EP2018871A1 Immunological methods to modulate myostatin in vertebrate subjects |
| 01/28/2009 | EP2018869A1 Licorice polyphenol preparation |
| 01/28/2009 | EP2018863A1 Fused heterocyclic compound and use thereof |
| 01/28/2009 | EP2018855A1 Pharmaceutical agent |
| 01/28/2009 | EP2018853A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor |
| 01/28/2009 | EP1541672B1 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/28/2009 | EP1495024B1 Dipyridodiazepinones as reverse transcriptase inhibitors |
| 01/28/2009 | EP1435927B1 Use of totarol for the treatment of pruritus |
| 01/28/2009 | EP1418910B1 Methods for inhibiting or reversing tau filament formation polymerization |
| 01/28/2009 | EP1372716B1 Blood cell production via activation of cd163 |
| 01/28/2009 | EP1207755B1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation |
| 01/28/2009 | EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 01/28/2009 | CN101352435A Use of lipoamide for preventing and treating age related macular degeneration |
| 01/28/2009 | CN100455595C Protein of interreaction with karyomitosis primary activator protein kinase p38 and its coding gene and application |
| 01/28/2009 | CN100455292C Anti-fatigue formulating prescription |
| 01/27/2009 | US7482465 Indol derivatives and their use as 5-HT ligands |
| 01/27/2009 | US7482462 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 01/27/2009 | US7482458 Quinoline derivatives |
| 01/27/2009 | US7482437 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/27/2009 | US7482434 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482369 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 01/27/2009 | US7482368 Triamide-substituted heterobicyclic compounds |
| 01/27/2009 | US7482365 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases |
| 01/27/2009 | US7482363 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens |
| 01/27/2009 | US7482339 Cannabinoid receptor agonists; antipruritic agents, analgesics, bronchodilator agents |
| 01/27/2009 | US7482324 Bone morphogenic protein for identifying modulators for treatment of bone diseases |
| 01/27/2009 | US7482320 Modulation of smooth muscle cell proliferation |
| 01/27/2009 | US7482138 PAK5-related compositions and methods |
| 01/27/2009 | US7482013 Albumin fusion proteins |